Comparative study of idursulfase beta and idursulfase in vitro and in vivoKim, Chihwa; Seo, Jinwook; Chung, Yokyung; Ji, Hyi-Jeong; Lee, Jaehyeon; Sohn, Jongmun; Lee, Byoungju; Jo, Eui-cheol · Journal of Human Genetics · 2016

Immune modulation in a patient with mucopolysaccharidosis II (MPSII) on idursulfase therapy with high titer anti-idursulfase antibodiesBurton, Barbara; Kim, Katherine; Widera, Shanna; Thomas, Janet; Messinger, Yoav · Molecular Genetics and Metabolism · 2013

Evaluation of impact of anti-idursulfase antibodies during long-term idursulfase enzyme replacement therapy in mucopolysaccharidosis II patientsGiugliani, R.; Harmatz, P.; Jones, S.A.; Mendelsohn, N.J.; Vellodi, A.; Qiu, Y.; Hendriksz, C.J.; Vijayaraghavan, S.; Whiteman, D.A.H.; Pano, A. · Molecular Genetics and Metabolism Reports · 2017

The relationship between anti-idursulfase antibody status and safety and efficacy outcomes in attenuated mucopolysaccharidosis II patients aged 5years and older treated with intravenous idursulfaseBarbier, A.J.; Bielefeld, B.; Whiteman, D.A.H.; Natarajan, M.; Pano, A.; Amato, D.A. · Molecular Genetics and Metabolism · 2013

Idursulfase approved in Brazil for MPS II.2008

Idursulfase approved in Mexico2008

Idursulfase effective in MPS type II2005

Idursulfase clinically active in type II mucopolysaccharidosis2003

Biperiden/trihexyphenidylReactions Weekly · 1995

NitrendipineReactions Weekly · 2003

ScopolamineReactions Weekly · 2007

ScopolamineReactions Weekly · 2012

ScopolamineReactions Weekly · 2009

Centella asiaticaReactions Weekly · 2011

Daunorubicin/mitoxantroneReactions Weekly · 2007

AnthracyclinesReactions Weekly · 1991